Anti-coagulation drugs Flashcards

1
Q

MoA of warfarin

A

Competitively inhibits reduction of oxidised vitamin K to prevent synthesis of factors 2,7,9,10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Why can increasing vitamin K reverse warfarin

A

Warfarin is a competitive inhibitor so increasing vitamin K counteracts warfarin action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Indications for warfarin and target INR for each

A

2-3 for DVT, PE, AF, stroke

2.5-4.5 for mechanical heart valves, thrombophilia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Consequences of warfarin onset and offset speed

A

Slow onset so need initial heparin cover

Slow offset so should stop 3-5 days before surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Consequences of warfarin use in pregnancy

A

Early - teratogenic

Late - brain haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Warfarin potentiators and their MoA

i.e things which will raise INR

A

CYP450 inhibitors - amiodarone, quinolone, cemetidine, alcohol, metronidazole
Platelet inhibitors - aspirin
Displace protein bound warfarin - NSAIDs
Decrease vitamin K from gut flora - cephalosporin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Warfarin inhibitors and their MoA

i.e things that will decrease INR

A

CYP450 inducers - rifampicin, St. John’s wort, anti epileptics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What should be considered before initiating warfarin treatment

A
Falls risk score
INR 
LFT
Platelets 
Drug history 
Compliance likely?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What needs monitoring in warfarin therapy

A

INR
Prothrombin time
People with thyroid disease need close monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Side effects of warfarin

A

Bruising

Bleeding - intracranial, GI, epistaxis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Warfarin reversal protocol for different INR ranges

A

INR 4-8 with no bleeding: withhold 1 or 2 doses of warfarin
INR 4-8 with minor bleeding or INR >8 with no bleeding: stop warfarin and give oral vitamin K
INR >8 with minor bleeding: stop warfarin and give IV vitamin K
Major bleeding: stop warfarin, give IV vitamin K, give prothrombin complex concentrate
Need cardiology advice if patient has mechanical valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Action of heparin

A

Activates antithrombin-III which inhibits thrombin and factors 9,10,11,12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Differences between types of heparin drugs MoA

Explain why this is the case

A

Unfractionated - inhibits thrombin and factor Xa
Low molecular weight - only inhibits factor Xa

Inhibition of thrombin by AT-III requires heparin and thrombin to bind simultaneously, only unfractionated heparin is large enough

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Route of heparin administration

A

Parenterally as poor GI absorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dose response of heparin drugs

A

Unfractionated - non linear

Low molecular weight - predictable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Bioavailability of heparin drugs and consequence of this in clinical practice

A

Unfractionated - variable as binds to cells and proteins
Low molecular weight - >90%

Can’t calculate a loading dose of unfractionated heparin

17
Q

Monitoring of heparin drugs

A

Unfractionated - APTT

Low molecular weight - none, factor X assay?

18
Q

Administration of heparin drugs

A

Unfractionated - IV

Low molecular weight - subcutaneous

19
Q

Indications for heparin

A

Los dose for prevention of thromboembolism - before surgery, immobility
Treatment dose for DVT, PE, ACS to prevent clot propagation
Alternative to warfarin for pregnant women

20
Q

Side effects of heparin

A

Bruising
Bleeding
Heparin induced thrombocytopenia (autoimmune)
Osteoporosis in long term use

21
Q

Reversal for heparin and it’s MoA

A

Stop heparin and giving protamine sulphate

Irreversibly binds to heparin causing it to disassociate from AT-III

22
Q

MoA of dipyridamole

A

Phosphodiesterase inhibitor so decreases cAMP breakdown

Inhibits thromboxane A2 so is an antiplatelet

23
Q

MoA of clopidogrel

A

Platelet ADP receptor antagonist so is an antiplatelet

24
Q

MoA of tirofiban

When is it indicated

A

Decreases platelet cross linking by fibrinogen

For high risk ACS and post PCI

25
Q

MoA of the DOACs

A

Inhibit factor X - rivaroxaban, apixaban

Inhibit thrombin - dabigatran

26
Q

First line VTE treatment with cancer and with no cancer

A

Cancer: LMWH

No cancer: DOAC

27
Q

Pre and post op management of DOACs

A

Stop 24 hours (low bleeding risk) or 48 hours (high bleeding risk) pre op
Restart after 6-12 hours (low bleeding risk) or >48 hours (high bleeding risk)

28
Q

Advantage of dabigatran

A

Can be reversed by praxbind